We are pleased to announce the Mito Foundation Symposium will return this year on Thursday 23 September.
Held during World Mitochondrial Disease Week, this year's Symposium will bring together world-leading researchers and mito experts to discuss "Mitochondrial Donation: Beyond Legislative Change."
In anticipation of the passage of Mitochondrial Donation Law Reform (Maeve's Law) Bill 2021, the Symposium will explore how mitochondrial donation will be implemented in Australia. Maeve's Law is named in honour of five year old Maeve Hood who has mito.
The Symposium will bring together experts from the UK to share their experience following similar legislative change in the UK in 2015, as well as local patient, clinical, IVF and health systems experts.
The Symposium will be an online event, allowing you to join with ease. Please use the form below to sign-up for updates.
Please click on the session title for the session description and speakers.
Prof. Aleksandra Filipovska, will set the tone for this year's symposium with her welcome address.
Symposium Chair: Prof. Aleksandra Filipovska
Prof. Aleksandra Filipovska is a Deputy Director of the ARC Centre of Excellence in Synthetic biology, NHMRC Senior Research Fellow and Professor at the University of Western Australia. She received her PhD in 2002 from the University of Otago, New Zealand. From 2003-2005 she was a NZ Foundation for Research, Science and Technology Fellow at the MRC Mitochondrial Biology Unit in Cambridge, the United Kingdom. In 2006 she relocated to Australia as a NHMRC Howard Florey Fellow and established her research group at the Perkins Institute of Medical Research at the University of Western Australia.
She was an Australian Research Council Future Fellow until 2014 and since 2014 she has been a NHMRC Senior Research Fellow and Professor at UWA and the Harry Perkins Institute of Medical Research and established a Mitochondrial Disease Therapy group at Telethon Kids Institute in 2019. Her research interests are in the regulation of gene expression by RNA-binding proteins and the use of multi-omic technologies to elucidate their molecular functions in health and disease. Her research group uses genomic technologies and synthetic biology to design new models of mitochondrial diseases and develop treatments for these disorders.